Louise Bowman

7.2k total citations · 1 hit paper
52 papers, 1.3k citations indexed

About

Louise Bowman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Louise Bowman has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 13 papers in Economics and Econometrics. Recurrent topics in Louise Bowman's work include Lipoproteins and Cardiovascular Health (13 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Louise Bowman is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Louise Bowman collaborates with scholars based in United Kingdom, United States and Italy. Louise Bowman's co-authors include Rory Collins, Martin Landray, Richard Peto, Jane Armitage, Sarah Parish, Richard Bulbulia, Richard Haynes, Barbara Casadei, Nicholas Jones and Clare Taylor and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Louise Bowman

50 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Magic of Randomization versus the Myth of Real-World Evidence

2020 260 citations Rory Collins, Louise Bowman et al. New England Journal of Medicine profile →

Peers

Louise Bowman

CCM

SURGE

EDM

PRM

Jannick A N Dorresteijn Netherlands

Manuel R. Blum Switzerland

Natalie Staplin United Kingdom

Alexander C. Fanaroff United States

Lily G. Bessette United States

Brandon K. Bellows United States

Aldona Kubica Poland

Julien Bezin France

James S. Floyd United States

Kunal N. Karmali United States

Jannick A N Dorresteijn Netherlands

Louise Bowman

536 ×1.0

CCM

326 ×1.2

SURGE

205 ×0.9

306 ×1.5

EDM

49 ×0.3

PRM

Citations per year, relative to Louise Bowman Louise Bowman (= 1×) peers Jannick A N Dorresteijn

Countries citing papers authored by Louise Bowman

Since Specialization

Citations

This map shows the geographic impact of Louise Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Bowman more than expected).

Fields of papers citing papers by Louise Bowman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Bowman. The network helps show where Louise Bowman may publish in the future.

Co-authorship network of co-authors of Louise Bowman

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Bowman. A scholar is included among the top collaborators of Louise Bowman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Bowman. Louise Bowman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wijesurendra, Rohan S., Guilherme Pessoa-Amorim, Georgina Buck, et al.. (2025). Active Monitoring for AtriaL FIbrillation (AMALFI): Rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation. American Heart Journal. 290. 310–324. 2 indexed citations

Sammons, Emily, et al.. (2025). Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes. BMJ Open. 15(2). e090605–e090605.

Buccheri, Sergio, Stefan James, Marion Mafham, et al.. (2025). Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience. Trials. 26(1). 24–24. 1 indexed citations

Wijesurendra, Rohan S., Guilherme Pessoa-Amorim, Richard Bulbulia, et al.. (2023). Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation. EP Europace. 25(Supplement_1). 3 indexed citations

Williams, Claire, Jemma C. Hopewell, Emily Sammons, et al.. (2023). Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States. Journal of the American Heart Association. 12(19). e030766–e030766. 11 indexed citations

Parish, Sarah, Georgina Buck, Theingi Aung, et al.. (2023). Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial. Trials. 24(1). 166–166. 3 indexed citations

Bowman, Louise, Franz Weidinger, Michelle A. Albert, Edward T.A. Fry, & Fausto J. Pinto. (2022). Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation. Global Heart. 17(1). 85–85. 2 indexed citations

Collins, Rory, Louise Bowman, Martin Landray, & Richard Peto. (2020). The Magic of Randomization versus the Myth of Real-World Evidence. New England Journal of Medicine. 382(7). 674–678. 260 indexed citations breakdown →

Hopewell, Jemma C., Alison Offer, Richard Haynes, et al.. (2020). Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. European Heart Journal. 41(35). 3336–3342. 26 indexed citations

10.

Bowman, Louise, Aris Baras, Robert M. Califf, et al.. (2020). Understanding the use of observational and randomized data in cardiovascular medicine. European Heart Journal. 41(27). 2571–2578. 21 indexed citations

11.

Mafham, Marion, Louise Bowman, Richard Haynes, & Jane Armitage. (2019). Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study. Diabetologia. 63(5). 898–905. 5 indexed citations

12.

Llewellyn-Bennett, Rebecca, Danielle Edwards, Nia Roberts, et al.. (2018). Post-trial follow-up methodology in large randomised controlled trials: a systematic review. Trials. 19(1). 298–298. 28 indexed citations

13.

Bowman, Louise, Marion Mafham, Karl Wallendszus, et al.. (2018). Effects of aspirin for primary prevention in persons with diabetes mellitus: the ASCEND Study Collaborative Group. Journal of Vascular Surgery. 69(1). 305–305. 21 indexed citations

14.

Aung, Theingi, Georgina Buck, Sarah Parish, Louise Bowman, & Jane Armitage. (2017). P2088Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial. European Heart Journal. 38(suppl_1).

15.

Aung, Theingi, Richard Haynes, Jill Barton, et al.. (2016). Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND). Trials. 17(1). 286–286. 30 indexed citations

16.

Parish, Stanley T., Alison Offer, Alexander G. Thompson, et al.. (2010). Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality. Journal of Internal Medicine. 268. 348–358. 29 indexed citations

17.

Emberson, Jonathan, Leong L. Ng, Jane Armitage, et al.. (2007). N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection Study. Journal of the American College of Cardiology. 49(3). 311–319. 83 indexed citations

18.

Armitage, Jane & Louise Bowman. (2004). Cardiovascular outcomes among participants with diabetes in the recent large statin trials. Current Opinion in Lipidology. 15(4). 439–446. 29 indexed citations

19.

Bowman, Louise & Jane Armitage. (2002). Diabetes and Impaired Glucose Tolerance: A Review of the Epidemiological and Trial Evidence for Their Role in Cardiovascular Risk. Seminars in Vascular Medicine. 2(4). 383–390. 5 indexed citations

20.

Bowman, Louise. (1994). PUMPING UP THE VOLUME. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact